HDAC1 and Parkinson disease: In Parkinson’s disease, reduced Nrf2 signaling accelerates dopaminergic neuron loss, and heightened HDAC1 activity contributes to mitochondrial dysfunction and α-synuclein aggregation [4,5,6].